Home › Funds › First Pacific Advisors, LP › BIO
First Pacific Advisors, LP position in BIO
BIO RAD LABS INC · Industrials
First Pacific Advisors, LP reported holding 269,082 shares of BIO (BIO RAD LABS INC) in its Q3 2026 13F filing — a position valued at US$101.6M, representing 1.21% of its reported portfolio and ranking #32 among its reported holdings. First Pacific Advisors, LP has disclosed BIO holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How First Pacific Advisors, LP's BIO position evolved
First Pacific Advisors, LP first disclosed a stake in BIO in Q4 2023 at 4,866 shares (US$1.6M). The position peaked in Q4 2025 at 401,457 shares, worth US$121.6M. Across 12 filings, First Pacific Advisors, LP increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 269,082 shares valued at US$101.6M — a reduction of -132,779 shares quarter over quarter.. Notable position changes include a 2052% increase in Q1 2024 (shares fell 21% over the following quarter), a 53% increase in Q2 2024 (shares rose 23% over the following quarter), a 136% increase in Q1 2025 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 4.87K | $1.57M | New |
| Q1 2024 | 104.74K | $36.23M | Add |
| Q2 2024 | 160.55K | $43.85M | Add |
| Q3 2024 | 157.88K | $52.82M | Reduce |
| Q4 2024 | 157.85K | $51.86M | Hold |
| Q1 2025 | 372.56K | $90.74M | Add |
| Q2 2025 | 386.95K | $93.38M | Add |
| Q3 2025 | 394.41K | $110.59M | Add |
| Q4 2025 | 401.46K | $121.64M | Add |
| Q1 2026 | 407.36K | $113.55M | Add |
| Q2 2026 | 401.86K | $117.99M | Reduce |
| Q3 2026 | 269.08K | $101.63M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BIO and 13F data
BIO (BIO RAD LABS INC) is a Industrials company. 24 other funds we track also report a position in BIO — the largest reported positions include First Eagle Investment Management (US$927.5M), ARIEL INVESTMENTS, LLC (US$298.1M), EARNEST PARTNERS LLC (US$214.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BIO
- First Eagle Investment Management 2.46M sh · $927.50M · Q3 2026
- ARIEL INVESTMENTS, LLC 789.34K sh · $298.14M · Q3 2026
- EARNEST PARTNERS LLC 567.82K sh · $214.47M · Q3 2026
- NOMURA HOLDINGS INC 328.90K sh · $96.57M · Q2 2026
More on First Pacific Advisors, LP
FAQ
How long has First Pacific Advisors, LP held BIO?
First Pacific Advisors, LP has disclosed BIO holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is First Pacific Advisors, LP's current position in BIO?
As of Q3 2026, First Pacific Advisors, LP holds 269.08K shares of BIO (BIO RAD LABS INC), valued at $101.63M, representing 1.21% of its reported portfolio and ranking #32.
Has First Pacific Advisors, LP been buying or selling BIO?
In the latest 13F filing (Q3 2026), First Pacific Advisors, LP reduced its position in BIO. The position peaked in Q4 2025 at 401.46K shares.
Which other funds hold BIO?
Other major institutional holders of BIO include First Eagle Investment Management, ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.